#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Discussion
1-1	0-2	4.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_

#Text=Our study , conducted on a limited , though well characterized , number of young , healthy volunteers , aimed at comparing the autonomic response to cognitive and sensory tests to the best of our knowledge , and tried to fill in a significant gap in the existing literature .
2-1	14-17	Our	person|abstract[3]	acc|new[3]	ana	2-35
2-2	18-23	study	abstract[3]	new[3]	_	_
2-3	24-25	,	abstract[3]	new[3]	_	_
2-4	26-35	conducted	abstract[3]	new[3]	_	_
2-5	36-38	on	abstract[3]	new[3]	_	_
2-6	39-40	a	abstract[3]|abstract[4]	new[3]|new[4]	_	_
2-7	41-48	limited	abstract[3]|abstract[4]	new[3]|new[4]	_	_
2-8	49-50	,	abstract[3]|abstract[4]	new[3]|new[4]	_	_
2-9	51-57	though	abstract[3]|abstract[4]	new[3]|new[4]	_	_
2-10	58-62	well	abstract[3]|abstract[4]	new[3]|new[4]	_	_
2-11	63-76	characterized	abstract[3]|abstract[4]	new[3]|new[4]	_	_
2-12	77-78	,	abstract[3]|abstract[4]	new[3]|new[4]	_	_
2-13	79-85	number	abstract[3]|abstract[4]	new[3]|new[4]	_	_
2-14	86-88	of	abstract[3]|abstract[4]	new[3]|new[4]	_	_
2-15	89-94	young	abstract[3]|abstract[4]|person[5]	new[3]|new[4]|new[5]	coref	19-56[164_5]
2-16	95-96	,	abstract[3]|abstract[4]|person[5]	new[3]|new[4]|new[5]	_	_
2-17	97-104	healthy	abstract[3]|abstract[4]|person[5]	new[3]|new[4]|new[5]	_	_
2-18	105-115	volunteers	abstract[3]|abstract[4]|person[5]	new[3]|new[4]|new[5]	_	_
2-19	116-117	,	_	_	_	_
2-20	118-123	aimed	_	_	_	_
2-21	124-126	at	_	_	_	_
2-22	127-136	comparing	_	_	_	_
2-23	137-140	the	abstract[6]	new[6]	coref	3-19[15_6]
2-24	141-150	autonomic	abstract[6]	new[6]	_	_
2-25	151-159	response	abstract[6]	new[6]	_	_
2-26	160-162	to	abstract[6]	new[6]	_	_
2-27	163-172	cognitive	abstract[6]|abstract[7]	new[6]|new[7]	coref	12-26[108_7]
2-28	173-176	and	abstract[6]|abstract[7]	new[6]|new[7]	_	_
2-29	177-184	sensory	abstract[6]|abstract[7]	new[6]|new[7]	_	_
2-30	185-190	tests	abstract[6]|abstract[7]	new[6]|new[7]	_	_
2-31	191-193	to	_	_	_	_
2-32	194-197	the	_	_	_	_
2-33	198-202	best	_	_	_	_
2-34	203-205	of	_	_	_	_
2-35	206-209	our	person|abstract[9]	giv|new[9]	ana	4-18
2-36	210-219	knowledge	abstract[9]	new[9]	_	_
2-37	220-221	,	_	_	_	_
2-38	222-225	and	_	_	_	_
2-39	226-231	tried	_	_	_	_
2-40	232-234	to	_	_	_	_
2-41	235-239	fill	_	_	_	_
2-42	240-242	in	_	_	_	_
2-43	243-244	a	abstract[10]	new[10]	_	_
2-44	245-256	significant	abstract[10]	new[10]	_	_
2-45	257-260	gap	abstract[10]	new[10]	_	_
2-46	261-263	in	abstract[10]	new[10]	_	_
2-47	264-267	the	abstract[10]|abstract[11]	new[10]|new[11]	_	_
2-48	268-276	existing	abstract[10]|abstract[11]	new[10]|new[11]	_	_
2-49	277-287	literature	abstract[10]|abstract[11]	new[10]|new[11]	_	_
2-50	288-289	.	_	_	_	_

#Text=With respect to the baseline , the presentation of the six different olfactory stimuli was seen to elicit a significant response in terms of activation of the sympathetic branch of the ANS .
3-1	290-294	With	_	_	_	_
3-2	295-302	respect	_	_	_	_
3-3	303-305	to	_	_	_	_
3-4	306-309	the	abstract[12]	new[12]	_	_
3-5	310-318	baseline	abstract[12]	new[12]	_	_
3-6	319-320	,	_	_	_	_
3-7	321-324	the	event[13]	new[13]	_	_
3-8	325-337	presentation	event[13]	new[13]	_	_
3-9	338-340	of	event[13]	new[13]	_	_
3-10	341-344	the	event[13]|abstract[14]	new[13]|new[14]	_	_
3-11	345-348	six	event[13]|abstract[14]	new[13]|new[14]	_	_
3-12	349-358	different	event[13]|abstract[14]	new[13]|new[14]	_	_
3-13	359-368	olfactory	event[13]|abstract[14]	new[13]|new[14]	_	_
3-14	369-376	stimuli	event[13]|abstract[14]	new[13]|new[14]	_	_
3-15	377-380	was	_	_	_	_
3-16	381-385	seen	_	_	_	_
3-17	386-388	to	_	_	_	_
3-18	389-395	elicit	_	_	_	_
3-19	396-397	a	abstract[15]	giv[15]	coref	10-16[92_15]
3-20	398-409	significant	abstract[15]	giv[15]	_	_
3-21	410-418	response	abstract[15]	giv[15]	_	_
3-22	419-421	in	abstract[15]	giv[15]	_	_
3-23	422-427	terms	abstract[15]	giv[15]	_	_
3-24	428-430	of	abstract[15]	giv[15]	_	_
3-25	431-441	activation	abstract[15]|event[16]	giv[15]|new[16]	coref	9-42[86_16]
3-26	442-444	of	abstract[15]|event[16]	giv[15]|new[16]	_	_
3-27	445-448	the	abstract[15]|event[16]|abstract[17]	giv[15]|new[16]|new[17]	_	_
3-28	449-460	sympathetic	abstract[15]|event[16]|abstract[17]	giv[15]|new[16]|new[17]	_	_
3-29	461-467	branch	abstract[15]|event[16]|abstract[17]	giv[15]|new[16]|new[17]	_	_
3-30	468-470	of	abstract[15]|event[16]|abstract[17]	giv[15]|new[16]|new[17]	_	_
3-31	471-474	the	abstract[15]|event[16]|abstract[17]|abstract[18]	giv[15]|new[16]|new[17]|new[18]	coref	7-15[0_18]
3-32	475-478	ANS	abstract[15]|event[16]|abstract[17]|abstract[18]	giv[15]|new[16]|new[17]|new[18]	_	_
3-33	479-480	.	_	_	_	_

#Text=Having reported that the olfactory compounds used included odors normally judged as both pleasant and unpleasant , our findings are somewhat similar to the retrievals of Bensafi et al. , limited to unpleasant odors .
4-1	481-487	Having	_	_	_	_
4-2	488-496	reported	_	_	_	_
4-3	497-501	that	_	_	_	_
4-4	502-505	the	substance[19]	new[19]	_	_
4-5	506-515	olfactory	substance[19]	new[19]	_	_
4-6	516-525	compounds	substance[19]	new[19]	_	_
4-7	526-530	used	substance[19]	new[19]	_	_
4-8	531-539	included	_	_	_	_
4-9	540-545	odors	abstract[20]	new[20]	coref	4-33[25_20]
4-10	546-554	normally	abstract[20]	new[20]	_	_
4-11	555-561	judged	abstract[20]	new[20]	_	_
4-12	562-564	as	abstract[20]	new[20]	_	_
4-13	565-569	both	abstract[20]	new[20]	_	_
4-14	570-578	pleasant	abstract[20]	new[20]	_	_
4-15	579-582	and	abstract[20]	new[20]	_	_
4-16	583-593	unpleasant	abstract[20]	new[20]	_	_
4-17	594-595	,	_	_	_	_
4-18	596-599	our	person|abstract[22]	giv|new[22]	ana|coref	5-4|8-30[69_22]
4-19	600-608	findings	abstract[22]	new[22]	_	_
4-20	609-612	are	_	_	_	_
4-21	613-621	somewhat	_	_	_	_
4-22	622-629	similar	_	_	_	_
4-23	630-632	to	_	_	_	_
4-24	633-636	the	event[23]	new[23]	_	_
4-25	637-647	retrievals	event[23]	new[23]	_	_
4-26	648-650	of	event[23]	new[23]	_	_
4-27	651-658	Bensafi	event[23]|person	new[23]|new	_	_
4-28	659-661	et	event[23]	new[23]	_	_
4-29	662-665	al.	event[23]	new[23]	_	_
4-30	666-667	,	event[23]	new[23]	_	_
4-31	668-675	limited	event[23]	new[23]	_	_
4-32	676-678	to	event[23]	new[23]	_	_
4-33	679-689	unpleasant	event[23]|abstract[25]	new[23]|giv[25]	_	_
4-34	690-695	odors	event[23]|abstract[25]	new[23]|giv[25]	_	_
4-35	696-697	.	_	_	_	_

#Text=In addition , we also failed to find significant correlations between autonomic parameters and odor pleasantness , confirming that pleasant versus unpleasant odors do not cause significantly different autonomic responses in healthy subjects .
5-1	698-700	In	_	_	_	_
5-2	701-709	addition	_	_	_	_
5-3	710-711	,	_	_	_	_
5-4	712-714	we	person	giv	ana	8-30
5-5	715-719	also	_	_	_	_
5-6	720-726	failed	_	_	_	_
5-7	727-729	to	_	_	_	_
5-8	730-734	find	_	_	_	_
5-9	735-746	significant	abstract[27]	new[27]	coref	22-12[190_27]
5-10	747-759	correlations	abstract[27]	new[27]	_	_
5-11	760-767	between	abstract[27]	new[27]	_	_
5-12	768-777	autonomic	abstract[27]|abstract[28]	new[27]|new[28]	coref	22-24[194_28]
5-13	778-788	parameters	abstract[27]|abstract[28]	new[27]|new[28]	_	_
5-14	789-792	and	abstract[27]	new[27]	_	_
5-15	793-797	odor	abstract[27]|abstract|abstract[30]	new[27]|new|new[30]	_	_
5-16	798-810	pleasantness	abstract[27]|abstract[30]	new[27]|new[30]	_	_
5-17	811-812	,	_	_	_	_
5-18	813-823	confirming	_	_	_	_
5-19	824-828	that	_	_	_	_
5-20	829-837	pleasant	abstract[31]	new[31]	_	_
5-21	838-844	versus	abstract[31]	new[31]	_	_
5-22	845-855	unpleasant	abstract[31]	new[31]	_	_
5-23	856-861	odors	abstract[31]	new[31]	_	_
5-24	862-864	do	_	_	_	_
5-25	865-868	not	_	_	_	_
5-26	869-874	cause	_	_	_	_
5-27	875-888	significantly	abstract[32]	new[32]	coref	9-4[72_32]
5-28	889-898	different	abstract[32]	new[32]	_	_
5-29	899-908	autonomic	abstract[32]	new[32]	_	_
5-30	909-918	responses	abstract[32]	new[32]	_	_
5-31	919-921	in	_	_	_	_
5-32	922-929	healthy	animal[33]	new[33]	coref	12-22[106_33]
5-33	930-938	subjects	animal[33]	new[33]	_	_
5-34	939-940	.	_	_	_	_

#Text=After the olfactory stimulation , the TSST further increased the SNS activity , at the same time highlighting a somewhat parasympathetic withdrawal , as demonstrated by the simultaneous decrease of both SDNN and pNN50 .
6-1	941-946	After	_	_	_	_
6-2	947-950	the	event[34]	new[34]	coref	9-7[73_34]
6-3	951-960	olfactory	event[34]	new[34]	_	_
6-4	961-972	stimulation	event[34]	new[34]	_	_
6-5	973-974	,	_	_	_	_
6-6	975-978	the	abstract[35]	new[35]	coref	7-9[43_35]
6-7	979-983	TSST	abstract[35]	new[35]	_	_
6-8	984-991	further	_	_	_	_
6-9	992-1001	increased	_	_	_	_
6-10	1002-1005	the	abstract[37]	new[37]	coref	13-29[122_37]
6-11	1006-1009	SNS	abstract|abstract[37]	new|new[37]	coref	9-43
6-12	1010-1018	activity	abstract[37]	new[37]	_	_
6-13	1019-1020	,	_	_	_	_
6-14	1021-1023	at	_	_	_	_
6-15	1024-1027	the	time[38]	new[38]	_	_
6-16	1028-1032	same	time[38]	new[38]	_	_
6-17	1033-1037	time	time[38]	new[38]	_	_
6-18	1038-1050	highlighting	_	_	_	_
6-19	1051-1052	a	event[39]	new[39]	coref	13-16[117_39]
6-20	1053-1061	somewhat	event[39]	new[39]	_	_
6-21	1062-1077	parasympathetic	event[39]	new[39]	_	_
6-22	1078-1088	withdrawal	event[39]	new[39]	_	_
6-23	1089-1090	,	_	_	_	_
6-24	1091-1093	as	_	_	_	_
6-25	1094-1106	demonstrated	_	_	_	_
6-26	1107-1109	by	_	_	_	_
6-27	1110-1113	the	event[40]	new[40]	_	_
6-28	1114-1126	simultaneous	event[40]	new[40]	_	_
6-29	1127-1135	decrease	event[40]	new[40]	_	_
6-30	1136-1138	of	event[40]	new[40]	_	_
6-31	1139-1143	both	event[40]|abstract[41]	new[40]|new[41]	_	_
6-32	1144-1148	SDNN	event[40]|abstract[41]	new[40]|new[41]	_	_
6-33	1149-1152	and	event[40]	new[40]	_	_
6-34	1153-1158	pNN50	event[40]|abstract	new[40]|new	_	_
6-35	1159-1160	.	_	_	_	_

#Text=Despite not being extensively studied with respect to the TSST , this kind of ANS behavior is consistent with the results by Boesch et al. , which , with a slightly different protocol , found an increase in HR together with a contextual decrease of HRV features during the administration of the TSST for groups ( TSST-G ) .
7-1	1161-1168	Despite	_	_	_	_
7-2	1169-1172	not	_	_	_	_
7-3	1173-1178	being	_	_	_	_
7-4	1179-1190	extensively	_	_	_	_
7-5	1191-1198	studied	_	_	_	_
7-6	1199-1203	with	_	_	_	_
7-7	1204-1211	respect	_	_	_	_
7-8	1212-1214	to	_	_	_	_
7-9	1215-1218	the	abstract[43]	giv[43]	coref	7-52[56_43]
7-10	1219-1223	TSST	abstract[43]	giv[43]	_	_
7-11	1224-1225	,	_	_	_	_
7-12	1226-1230	this	_	_	_	_
7-13	1231-1235	kind	abstract[45]	new[45]	coref	15-23[136_45]
7-14	1236-1238	of	abstract[45]	new[45]	_	_
7-15	1239-1242	ANS	abstract|abstract[45]	giv|new[45]	coref	9-4
7-16	1243-1251	behavior	abstract[45]	new[45]	_	_
7-17	1252-1254	is	_	_	_	_
7-18	1255-1265	consistent	_	_	_	_
7-19	1266-1270	with	_	_	_	_
7-20	1271-1274	the	abstract[46]	new[46]	coref	8-1[59_46]
7-21	1275-1282	results	abstract[46]	new[46]	_	_
7-22	1283-1285	by	abstract[46]	new[46]	_	_
7-23	1286-1292	Boesch	abstract[46]|person	new[46]|new	_	_
7-24	1293-1295	et	abstract[46]|abstract	new[46]|new	_	_
7-25	1296-1299	al.	abstract[46]	new[46]	_	_
7-26	1300-1301	,	abstract[46]	new[46]	_	_
7-27	1302-1307	which	abstract[46]	new[46]	_	_
7-28	1308-1309	,	abstract[46]	new[46]	_	_
7-29	1310-1314	with	abstract[46]	new[46]	_	_
7-30	1315-1316	a	abstract[46]|abstract[49]	new[46]|new[49]	coref	9-11[75_49]
7-31	1317-1325	slightly	abstract[46]|abstract[49]	new[46]|new[49]	_	_
7-32	1326-1335	different	abstract[46]|abstract[49]	new[46]|new[49]	_	_
7-33	1336-1344	protocol	abstract[46]|abstract[49]	new[46]|new[49]	_	_
7-34	1345-1346	,	abstract[46]	new[46]	_	_
7-35	1347-1352	found	abstract[46]	new[46]	_	_
7-36	1353-1355	an	abstract[46]|abstract[50]	new[46]|new[50]	_	_
7-37	1356-1364	increase	abstract[46]|abstract[50]	new[46]|new[50]	_	_
7-38	1365-1367	in	abstract[46]|abstract[50]	new[46]|new[50]	_	_
7-39	1368-1370	HR	abstract[46]|abstract[50]|abstract	new[46]|new[50]|new	coref	8-6
7-40	1371-1379	together	abstract[46]	new[46]	_	_
7-41	1380-1384	with	abstract[46]	new[46]	_	_
7-42	1385-1386	a	abstract[46]|event[52]	new[46]|new[52]	_	_
7-43	1387-1397	contextual	abstract[46]|event[52]	new[46]|new[52]	_	_
7-44	1398-1406	decrease	abstract[46]|event[52]	new[46]|new[52]	_	_
7-45	1407-1409	of	abstract[46]|event[52]	new[46]|new[52]	_	_
7-46	1410-1413	HRV	abstract[46]|event[52]|abstract|abstract[54]	new[46]|new[52]|new|new[54]	coref|coref	8-9|26-10[209_54]
7-47	1414-1422	features	abstract[46]|event[52]|abstract[54]	new[46]|new[52]|new[54]	_	_
7-48	1423-1429	during	abstract[46]	new[46]	_	_
7-49	1430-1433	the	abstract[46]|event[55]	new[46]|new[55]	_	_
7-50	1434-1448	administration	abstract[46]|event[55]	new[46]|new[55]	_	_
7-51	1449-1451	of	abstract[46]|event[55]	new[46]|new[55]	_	_
7-52	1452-1455	the	abstract[46]|event[55]|abstract[56]	new[46]|new[55]|giv[56]	coref	8-12[0_56]
7-53	1456-1460	TSST	abstract[46]|event[55]|abstract[56]	new[46]|new[55]|giv[56]	_	_
7-54	1461-1464	for	abstract[46]|event[55]|abstract[56]	new[46]|new[55]|giv[56]	_	_
7-55	1465-1471	groups	abstract[46]|event[55]|abstract[56]|animal	new[46]|new[55]|giv[56]|new	_	_
7-56	1472-1473	(	_	_	_	_
7-57	1474-1480	TSST-G	abstract	new	_	_
7-58	1481-1482	)	_	_	_	_
7-59	1483-1484	.	_	_	_	_

#Text=Similar results in terms of HR augmentation and HRV reduction under TSST stress were also found in several other protocols ( see ) , strengthening the scientific value of our findings .
8-1	1485-1492	Similar	abstract[59]	giv[59]	coref	26-3[207_59]
8-2	1493-1500	results	abstract[59]	giv[59]	_	_
8-3	1501-1503	in	abstract[59]	giv[59]	_	_
8-4	1504-1509	terms	abstract[59]	giv[59]	_	_
8-5	1510-1512	of	abstract[59]	giv[59]	_	_
8-6	1513-1515	HR	abstract[59]|abstract|abstract[61]	giv[59]|giv|new[61]	_	_
8-7	1516-1528	augmentation	abstract[59]|abstract[61]	giv[59]|new[61]	_	_
8-8	1529-1532	and	abstract[59]	giv[59]	_	_
8-9	1533-1536	HRV	abstract[59]|abstract|abstract[63]	giv[59]|giv|new[63]	_	_
8-10	1537-1546	reduction	abstract[59]|abstract[63]	giv[59]|new[63]	_	_
8-11	1547-1552	under	abstract[59]|abstract[63]	giv[59]|new[63]	_	_
8-12	1553-1557	TSST	abstract[59]|abstract[63]|abstract|abstract[65]	giv[59]|new[63]|giv|new[65]	coref|coref	9-12|10-11[0_65]
8-13	1558-1564	stress	abstract[59]|abstract[63]|abstract[65]	giv[59]|new[63]|new[65]	_	_
8-14	1565-1569	were	_	_	_	_
8-15	1570-1574	also	_	_	_	_
8-16	1575-1580	found	_	_	_	_
8-17	1581-1583	in	_	_	_	_
8-18	1584-1591	several	abstract[66]	new[66]	coref	22-1[188_66]
8-19	1592-1597	other	abstract[66]	new[66]	_	_
8-20	1598-1607	protocols	abstract[66]	new[66]	_	_
8-21	1608-1609	(	_	_	_	_
8-22	1610-1613	see	_	_	_	_
8-23	1614-1615	)	_	_	_	_
8-24	1616-1617	,	_	_	_	_
8-25	1618-1631	strengthening	_	_	_	_
8-26	1632-1635	the	abstract[67]	new[67]	_	_
8-27	1636-1646	scientific	abstract[67]	new[67]	_	_
8-28	1647-1652	value	abstract[67]	new[67]	_	_
8-29	1653-1655	of	abstract[67]	new[67]	_	_
8-30	1656-1659	our	abstract[67]|person|abstract[69]	new[67]|giv|giv[69]	coref|ana	17-1[139_69]|20-18
8-31	1660-1668	findings	abstract[67]|abstract[69]	new[67]|giv[69]	_	_
8-32	1669-1670	.	_	_	_	_

#Text=The comparison between ANS responses to olfactory stimulation and to the TSST protocol made it possible to compare Task I and Task II , as well as Task II and Task III responses , and highlighted a much higher contribution to the SNS activation borne by the TSST .
9-1	1671-1674	The	abstract[70]	new[70]	_	_
9-2	1675-1685	comparison	abstract[70]	new[70]	_	_
9-3	1686-1693	between	abstract[70]	new[70]	_	_
9-4	1694-1697	ANS	abstract[70]|abstract|abstract[72]	new[70]|giv|giv[72]	coref|coref	9-28[83_72]|11-8
9-5	1698-1707	responses	abstract[70]|abstract[72]	new[70]|giv[72]	_	_
9-6	1708-1710	to	abstract[70]|abstract[72]	new[70]|giv[72]	_	_
9-7	1711-1720	olfactory	abstract[70]|abstract[72]|event[73]	new[70]|giv[72]|giv[73]	coref	11-4[95_73]
9-8	1721-1732	stimulation	abstract[70]|abstract[72]|event[73]	new[70]|giv[72]|giv[73]	_	_
9-9	1733-1736	and	_	_	_	_
9-10	1737-1739	to	_	_	_	_
9-11	1740-1743	the	abstract[75]	giv[75]	ana	9-15[0_75]
9-12	1744-1748	TSST	abstract|abstract[75]	giv|giv[75]	coref	9-47[87_0]
9-13	1749-1757	protocol	abstract[75]	giv[75]	_	_
9-14	1758-1762	made	_	_	_	_
9-15	1763-1765	it	abstract	giv	coref	13-21[119_0]
9-16	1766-1774	possible	_	_	_	_
9-17	1775-1777	to	_	_	_	_
9-18	1778-1785	compare	_	_	_	_
9-19	1786-1790	Task	abstract[77]	new[77]	coref	9-22[78_77]
9-20	1791-1792	I	abstract[77]	new[77]	_	_
9-21	1793-1796	and	_	_	_	_
9-22	1797-1801	Task	abstract[78]	giv[78]	coref	9-28[0_78]
9-23	1802-1804	II	abstract[78]|abstract	giv[78]|new	_	_
9-24	1805-1806	,	_	_	_	_
9-25	1807-1809	as	_	_	_	_
9-26	1810-1814	well	_	_	_	_
9-27	1815-1817	as	_	_	_	_
9-28	1818-1822	Task	abstract|abstract[83]	giv|giv[83]	coref	9-31
9-29	1823-1825	II	abstract[83]	giv[83]	_	_
9-30	1826-1829	and	abstract[83]	giv[83]	_	_
9-31	1830-1834	Task	abstract|abstract[83]	giv|giv[83]	coref	10-8[90_0]
9-32	1835-1838	III	person|abstract[83]	new|giv[83]	ana	28-19[233_0]
9-33	1839-1848	responses	abstract[83]	giv[83]	_	_
9-34	1849-1850	,	_	_	_	_
9-35	1851-1854	and	_	_	_	_
9-36	1855-1866	highlighted	_	_	_	_
9-37	1867-1868	a	abstract[84]	new[84]	_	_
9-38	1869-1873	much	abstract[84]	new[84]	_	_
9-39	1874-1880	higher	abstract[84]	new[84]	_	_
9-40	1881-1893	contribution	abstract[84]	new[84]	_	_
9-41	1894-1896	to	abstract[84]	new[84]	_	_
9-42	1897-1900	the	abstract[84]|event[86]	new[84]|giv[86]	coref	11-8[97_86]
9-43	1901-1904	SNS	abstract[84]|abstract|event[86]	new[84]|giv|giv[86]	coref	11-11[98_0]
9-44	1905-1915	activation	abstract[84]|event[86]	new[84]|giv[86]	_	_
9-45	1916-1921	borne	abstract[84]|event[86]	new[84]|giv[86]	_	_
9-46	1922-1924	by	abstract[84]|event[86]	new[84]|giv[86]	_	_
9-47	1925-1928	the	abstract[84]|event[86]|abstract[87]	new[84]|giv[86]|giv[87]	coref	10-3[0_87]
9-48	1929-1933	TSST	abstract[84]|event[86]|abstract[87]	new[84]|giv[86]|giv[87]	_	_
9-49	1934-1935	.	_	_	_	_

#Text=Therefore , TSST was confirmed to represent a powerful psychosocial stress task capable to induce an acute stress response of all main physiologic stress systems .
10-1	1936-1945	Therefore	_	_	_	_
10-2	1946-1947	,	_	_	_	_
10-3	1948-1952	TSST	abstract	giv	coref	12-13
10-4	1953-1956	was	_	_	_	_
10-5	1957-1966	confirmed	_	_	_	_
10-6	1967-1969	to	_	_	_	_
10-7	1970-1979	represent	_	_	_	_
10-8	1980-1981	a	abstract[90]	giv[90]	coref	13-11[0_90]
10-9	1982-1990	powerful	abstract[90]	giv[90]	_	_
10-10	1991-2003	psychosocial	abstract[90]	giv[90]	_	_
10-11	2004-2010	stress	abstract|abstract[90]	giv|giv[90]	coref	10-18
10-12	2011-2015	task	abstract[90]	giv[90]	_	_
10-13	2016-2023	capable	abstract[90]	giv[90]	_	_
10-14	2024-2026	to	abstract[90]	giv[90]	_	_
10-15	2027-2033	induce	abstract[90]	giv[90]	_	_
10-16	2034-2036	an	abstract[90]|abstract[92]	giv[90]|giv[92]	coref	12-4[100_92]
10-17	2037-2042	acute	abstract[90]|abstract[92]	giv[90]|giv[92]	_	_
10-18	2043-2049	stress	abstract[90]|abstract|abstract[92]	giv[90]|giv|giv[92]	coref	10-24
10-19	2050-2058	response	abstract[90]|abstract[92]	giv[90]|giv[92]	_	_
10-20	2059-2061	of	abstract[90]|abstract[92]	giv[90]|giv[92]	_	_
10-21	2062-2065	all	abstract[90]|abstract[92]|abstract[94]	giv[90]|giv[92]|new[94]	_	_
10-22	2066-2070	main	abstract[90]|abstract[92]|abstract[94]	giv[90]|giv[92]|new[94]	_	_
10-23	2071-2082	physiologic	abstract[90]|abstract[92]|abstract[94]	giv[90]|giv[92]|new[94]	_	_
10-24	2083-2089	stress	abstract[90]|abstract[92]|abstract|abstract[94]	giv[90]|giv[92]|giv|new[94]	coref	12-19
10-25	2090-2097	systems	abstract[90]|abstract[92]|abstract[94]	giv[90]|giv[92]|new[94]	_	_
10-26	2098-2099	.	_	_	_	_

#Text=In addition , olfactory stimulation also elicited ANS activation ( particularly SNS )
11-1	2100-2102	In	_	_	_	_
11-2	2103-2111	addition	_	_	_	_
11-3	2112-2113	,	_	_	_	_
11-4	2114-2123	olfactory	event[95]	giv[95]	coref	24-20[204_95]
11-5	2124-2135	stimulation	event[95]	giv[95]	_	_
11-6	2136-2140	also	_	_	_	_
11-7	2141-2149	elicited	_	_	_	_
11-8	2150-2153	ANS	abstract|event[97]	giv|giv[97]	coref|coref	13-18|14-18[129_97]
11-9	2154-2164	activation	event[97]	giv[97]	_	_
11-10	2165-2166	(	_	_	_	_
11-11	2167-2179	particularly	abstract[98]	giv[98]	coref	13-30[0_98]
11-12	2180-2183	SNS	abstract[98]	giv[98]	_	_
11-13	2184-2185	)	_	_	_	_

#Text=The magnitude of this response was significantly smaller than that occurring with TSST , highlighting its usefulness in stress monitoring of subjects unable to undergo complex mathematical stress tests , limited to some particularly controlled experimental settings .
12-1	2186-2189	The	abstract[99]	new[99]	_	_
12-2	2190-2199	magnitude	abstract[99]	new[99]	_	_
12-3	2200-2202	of	abstract[99]	new[99]	_	_
12-4	2203-2207	this	abstract[99]|abstract[100]	new[99]|giv[100]	coref	28-25[236_100]
12-5	2208-2216	response	abstract[99]|abstract[100]	new[99]|giv[100]	_	_
12-6	2217-2220	was	_	_	_	_
12-7	2221-2234	significantly	_	_	_	_
12-8	2235-2242	smaller	_	_	_	_
12-9	2243-2247	than	_	_	_	_
12-10	2248-2252	that	_	_	_	_
12-11	2253-2262	occurring	_	_	_	_
12-12	2263-2267	with	_	_	_	_
12-13	2268-2272	TSST	abstract	giv	ana	12-16
12-14	2273-2274	,	_	_	_	_
12-15	2275-2287	highlighting	_	_	_	_
12-16	2288-2291	its	abstract|abstract[103]	giv|new[103]	coref	14-15
12-17	2292-2302	usefulness	abstract[103]	new[103]	_	_
12-18	2303-2305	in	abstract[103]	new[103]	_	_
12-19	2306-2312	stress	abstract[103]|abstract|event[105]	new[103]|giv|new[105]	coref	12-28
12-20	2313-2323	monitoring	abstract[103]|event[105]	new[103]|new[105]	_	_
12-21	2324-2326	of	abstract[103]|event[105]	new[103]|new[105]	_	_
12-22	2327-2335	subjects	abstract[103]|event[105]|animal[106]	new[103]|new[105]|giv[106]	coref	14-9[125_106]
12-23	2336-2342	unable	abstract[103]|event[105]|animal[106]	new[103]|new[105]|giv[106]	_	_
12-24	2343-2345	to	abstract[103]|event[105]|animal[106]	new[103]|new[105]|giv[106]	_	_
12-25	2346-2353	undergo	abstract[103]|event[105]|animal[106]	new[103]|new[105]|giv[106]	_	_
12-26	2354-2361	complex	abstract[103]|event[105]|animal[106]|abstract[108]	new[103]|new[105]|giv[106]|giv[108]	_	_
12-27	2362-2374	mathematical	abstract[103]|event[105]|animal[106]|abstract[108]	new[103]|new[105]|giv[106]|giv[108]	_	_
12-28	2375-2381	stress	abstract[103]|event[105]|animal[106]|abstract|abstract[108]	new[103]|new[105]|giv[106]|giv|giv[108]	coref	13-24
12-29	2382-2387	tests	abstract[103]|event[105]|animal[106]|abstract[108]	new[103]|new[105]|giv[106]|giv[108]	_	_
12-30	2388-2389	,	abstract[103]|event[105]|animal[106]	new[103]|new[105]|giv[106]	_	_
12-31	2390-2397	limited	abstract[103]|event[105]|animal[106]	new[103]|new[105]|giv[106]	_	_
12-32	2398-2400	to	abstract[103]|event[105]|animal[106]	new[103]|new[105]|giv[106]	_	_
12-33	2401-2405	some	abstract[103]|event[105]|animal[106]|abstract[109]	new[103]|new[105]|giv[106]|new[109]	_	_
12-34	2406-2418	particularly	abstract[103]|event[105]|animal[106]|abstract[109]	new[103]|new[105]|giv[106]|new[109]	_	_
12-35	2419-2429	controlled	abstract[103]|event[105]|animal[106]|abstract[109]	new[103]|new[105]|giv[106]|new[109]	_	_
12-36	2430-2442	experimental	abstract[103]|event[105]|animal[106]|abstract[109]	new[103]|new[105]|giv[106]|new[109]	_	_
12-37	2443-2451	settings	abstract[103]|event[105]|animal[106]|abstract[109]	new[103]|new[105]|giv[106]|new[109]	_	_
12-38	2452-2453	.	_	_	_	_

#Text=Interestingly , the trends noticed in the phase transition between Task III and recovery suggest an overall ANS withdrawal after a massive psycho-sensory stress protocol , being that both SNS and PNS activity decreased at this stage .
13-1	2454-2467	Interestingly	_	_	_	_
13-2	2468-2469	,	_	_	_	_
13-3	2470-2473	the	abstract[110]	new[110]	_	_
13-4	2474-2480	trends	abstract[110]	new[110]	_	_
13-5	2481-2488	noticed	abstract[110]	new[110]	_	_
13-6	2489-2491	in	abstract[110]	new[110]	_	_
13-7	2492-2495	the	abstract[110]|event[112]	new[110]|new[112]	_	_
13-8	2496-2501	phase	abstract[110]|abstract|event[112]	new[110]|new|new[112]	coref	13-36[123_0]
13-9	2502-2512	transition	abstract[110]|event[112]	new[110]|new[112]	_	_
13-10	2513-2520	between	abstract[110]|event[112]	new[110]|new[112]	_	_
13-11	2521-2525	Task	abstract[110]|event[112]|abstract|abstract[114]	new[110]|new[112]|giv|new[114]	_	_
13-12	2526-2529	III	abstract[110]|event[112]|abstract[114]	new[110]|new[112]|new[114]	_	_
13-13	2530-2533	and	abstract[110]|event[112]	new[110]|new[112]	_	_
13-14	2534-2542	recovery	abstract[110]|event[112]|event	new[110]|new[112]|new	coref	23-14
13-15	2543-2550	suggest	_	_	_	_
13-16	2551-2553	an	event[117]	giv[117]	_	_
13-17	2554-2561	overall	event[117]	giv[117]	_	_
13-18	2562-2565	ANS	abstract|event[117]	giv|giv[117]	coref	20-23
13-19	2566-2576	withdrawal	event[117]	giv[117]	_	_
13-20	2577-2582	after	event[117]	giv[117]	_	_
13-21	2583-2584	a	event[117]|abstract[119]	giv[117]|giv[119]	coref	14-14[127_119]
13-22	2585-2592	massive	event[117]|abstract[119]	giv[117]|giv[119]	_	_
13-23	2593-2607	psycho-sensory	event[117]|abstract[119]	giv[117]|giv[119]	_	_
13-24	2608-2614	stress	event[117]|abstract|abstract[119]	giv[117]|giv|giv[119]	coref	20-34
13-25	2615-2623	protocol	event[117]|abstract[119]	giv[117]|giv[119]	_	_
13-26	2624-2625	,	_	_	_	_
13-27	2626-2631	being	_	_	_	_
13-28	2632-2636	that	_	_	_	_
13-29	2637-2641	both	abstract[122]	giv[122]	_	_
13-30	2642-2645	SNS	abstract|abstract[122]	giv|giv[122]	_	_
13-31	2646-2649	and	abstract[122]	giv[122]	_	_
13-32	2650-2653	PNS	abstract|abstract[122]	new|giv[122]	coref	14-19
13-33	2654-2662	activity	abstract[122]	giv[122]	_	_
13-34	2663-2672	decreased	_	_	_	_
13-35	2673-2675	at	_	_	_	_
13-36	2676-2680	this	abstract[123]	giv[123]	coref	14-22[130_123]
13-37	2681-2686	stage	abstract[123]	giv[123]	_	_
13-38	2687-2688	.	_	_	_	_

#Text=Finally , the only significant correlation revealed that subjects who more quickly completing the TSST protocol displayed higher PNS activation in the following phase .
14-1	2689-2696	Finally	_	_	_	_
14-2	2697-2698	,	_	_	_	_
14-3	2699-2702	the	abstract[124]	new[124]	_	_
14-4	2703-2707	only	abstract[124]	new[124]	_	_
14-5	2708-2719	significant	abstract[124]	new[124]	_	_
14-6	2720-2731	correlation	abstract[124]	new[124]	_	_
14-7	2732-2740	revealed	_	_	_	_
14-8	2741-2745	that	_	_	_	_
14-9	2746-2754	subjects	animal[125]	giv[125]	coref	19-24[154_125]
14-10	2755-2758	who	animal[125]	giv[125]	_	_
14-11	2759-2763	more	animal[125]	giv[125]	_	_
14-12	2764-2771	quickly	animal[125]	giv[125]	_	_
14-13	2772-2782	completing	animal[125]	giv[125]	_	_
14-14	2783-2786	the	animal[125]|abstract[127]	giv[125]|giv[127]	coref	20-13[167_127]
14-15	2787-2791	TSST	animal[125]|abstract|abstract[127]	giv[125]|giv|giv[127]	_	_
14-16	2792-2800	protocol	animal[125]|abstract[127]	giv[125]|giv[127]	_	_
14-17	2801-2810	displayed	_	_	_	_
14-18	2811-2817	higher	event[129]	giv[129]	_	_
14-19	2818-2821	PNS	abstract|event[129]	giv|giv[129]	coref	15-12[133_0]
14-20	2822-2832	activation	event[129]	giv[129]	_	_
14-21	2833-2835	in	_	_	_	_
14-22	2836-2839	the	abstract[130]	giv[130]	coref	23-13[198_130]
14-23	2840-2849	following	abstract[130]	giv[130]	_	_
14-24	2850-2855	phase	abstract[130]	giv[130]	_	_
14-25	2856-2857	.	_	_	_	_

#Text=This result could be speculated in terms of sustained hyper-reactivity of the PNS , as a marker of increased selective attention and higher-order behavior and cognition ( e.g. , see ) .
15-1	2858-2862	This	abstract[131]	new[131]	_	_
15-2	2863-2869	result	abstract[131]	new[131]	_	_
15-3	2870-2875	could	_	_	_	_
15-4	2876-2878	be	_	_	_	_
15-5	2879-2889	speculated	_	_	_	_
15-6	2890-2892	in	_	_	_	_
15-7	2893-2898	terms	_	_	_	_
15-8	2899-2901	of	_	_	_	_
15-9	2902-2911	sustained	abstract[132]	new[132]	_	_
15-10	2912-2928	hyper-reactivity	abstract[132]	new[132]	_	_
15-11	2929-2931	of	abstract[132]	new[132]	_	_
15-12	2932-2935	the	abstract[132]|abstract[133]	new[132]|giv[133]	_	_
15-13	2936-2939	PNS	abstract[132]|abstract[133]	new[132]|giv[133]	_	_
15-14	2940-2941	,	_	_	_	_
15-15	2942-2944	as	_	_	_	_
15-16	2945-2946	a	abstract[134]	new[134]	_	_
15-17	2947-2953	marker	abstract[134]	new[134]	_	_
15-18	2954-2956	of	abstract[134]	new[134]	_	_
15-19	2957-2966	increased	abstract[134]|abstract[135]	new[134]|new[135]	_	_
15-20	2967-2976	selective	abstract[134]|abstract[135]	new[134]|new[135]	_	_
15-21	2977-2986	attention	abstract[134]|abstract[135]	new[134]|new[135]	_	_
15-22	2987-2990	and	abstract[134]	new[134]	_	_
15-23	2991-3003	higher-order	abstract[134]|abstract[136]	new[134]|giv[136]	_	_
15-24	3004-3012	behavior	abstract[134]|abstract[136]	new[134]|giv[136]	_	_
15-25	3013-3016	and	abstract[134]	new[134]	_	_
15-26	3017-3026	cognition	abstract[134]|abstract	new[134]|new	_	_
15-27	3027-3028	(	_	_	_	_
15-28	3029-3033	e.g.	_	_	_	_
15-29	3034-3035	,	_	_	_	_
15-30	3036-3039	see	_	_	_	_
15-31	3040-3041	)	_	_	_	_
15-32	3042-3043	.	_	_	_	_

#Text=Limitations
16-1	3044-3055	Limitations	abstract	new	coref	17-12[141_0]

#Text=All these findings should be taken into account in light of some limitations .
17-1	3056-3059	All	abstract[139]	giv[139]	_	_
17-2	3060-3065	these	abstract[139]	giv[139]	_	_
17-3	3066-3074	findings	abstract[139]	giv[139]	_	_
17-4	3075-3081	should	_	_	_	_
17-5	3082-3084	be	_	_	_	_
17-6	3085-3090	taken	_	_	_	_
17-7	3091-3095	into	_	_	_	_
17-8	3096-3103	account	_	_	_	_
17-9	3104-3106	in	_	_	_	_
17-10	3107-3112	light	abstract[140]	new[140]	_	_
17-11	3113-3115	of	abstract[140]	new[140]	_	_
17-12	3116-3120	some	abstract[140]|abstract[141]	new[140]|giv[141]	_	_
17-13	3121-3132	limitations	abstract[140]|abstract[141]	new[140]|giv[141]	_	_
17-14	3133-3134	.	_	_	_	_

#Text=First , the relatively small sample size does not allow drawing considerations based on subgroups ( e.g. , gender- or age-based , etc. ) .
18-1	3135-3140	First	_	_	_	_
18-2	3141-3142	,	_	_	_	_
18-3	3143-3146	the	abstract[143]	new[143]	_	_
18-4	3147-3157	relatively	abstract[143]	new[143]	_	_
18-5	3158-3163	small	abstract[143]	new[143]	_	_
18-6	3164-3170	sample	abstract|abstract[143]	new|new[143]	_	_
18-7	3171-3175	size	abstract[143]	new[143]	_	_
18-8	3176-3180	does	_	_	_	_
18-9	3181-3184	not	_	_	_	_
18-10	3185-3190	allow	_	_	_	_
18-11	3191-3198	drawing	abstract|abstract[145]	new|new[145]	coref	29-4[240_145]
18-12	3199-3213	considerations	abstract[145]	new[145]	_	_
18-13	3214-3219	based	abstract[145]	new[145]	_	_
18-14	3220-3222	on	abstract[145]	new[145]	_	_
18-15	3223-3232	subgroups	abstract[145]|abstract	new[145]|new	appos	18-17[147_0]
18-16	3233-3234	(	_	_	_	_
18-17	3235-3239	e.g.	abstract[147]	giv[147]	appos	18-21[0_147]
18-18	3240-3241	,	abstract[147]	giv[147]	_	_
18-19	3242-3249	gender-	abstract[147]	giv[147]	_	_
18-20	3250-3252	or	_	_	_	_
18-21	3253-3262	age-based	abstract	giv	_	_
18-22	3263-3264	,	_	_	_	_
18-23	3265-3269	etc.	_	_	_	_
18-24	3270-3271	)	_	_	_	_
18-25	3272-3273	.	_	_	_	_

#Text=This fact did not allow investigating the possible effects of confounding factors , including gender-specific ones ( i.e. , the sexual-hormone influences for female subjects , menstrual cycle phases , etc. ) or variables related to some physical characteristics of the subjects ( i.e. , the body mass index ) , even though none of the volunteers was apparently under- or overweight .
19-1	3274-3278	This	abstract[149]	new[149]	_	_
19-2	3279-3283	fact	abstract[149]	new[149]	_	_
19-3	3284-3287	did	_	_	_	_
19-4	3288-3291	not	_	_	_	_
19-5	3292-3297	allow	_	_	_	_
19-6	3298-3311	investigating	_	_	_	_
19-7	3312-3315	the	abstract[150]	new[150]	_	_
19-8	3316-3324	possible	abstract[150]	new[150]	_	_
19-9	3325-3332	effects	abstract[150]	new[150]	_	_
19-10	3333-3335	of	abstract[150]	new[150]	_	_
19-11	3336-3347	confounding	abstract[150]|abstract[151]	new[150]|new[151]	_	_
19-12	3348-3355	factors	abstract[150]|abstract[151]	new[150]|new[151]	_	_
19-13	3356-3357	,	abstract[150]|abstract[151]	new[150]|new[151]	_	_
19-14	3358-3367	including	abstract[150]|abstract[151]	new[150]|new[151]	_	_
19-15	3368-3383	gender-specific	abstract[150]|abstract[151]|abstract[152]	new[150]|new[151]|new[152]	appos	19-18[153_152]
19-16	3384-3388	ones	abstract[150]|abstract[151]|abstract[152]	new[150]|new[151]|new[152]	_	_
19-17	3389-3390	(	_	_	_	_
19-18	3391-3395	i.e.	abstract[153]	giv[153]	appos	19-27[156_153]
19-19	3396-3397	,	abstract[153]	giv[153]	_	_
19-20	3398-3401	the	abstract[153]	giv[153]	_	_
19-21	3402-3416	sexual-hormone	abstract[153]	giv[153]	_	_
19-22	3417-3427	influences	abstract[153]	giv[153]	_	_
19-23	3428-3431	for	abstract[153]	giv[153]	_	_
19-24	3432-3438	female	abstract[153]|animal[154]	giv[153]|giv[154]	coref	19-41[159_154]
19-25	3439-3447	subjects	abstract[153]|animal[154]	giv[153]|giv[154]	_	_
19-26	3448-3449	,	_	_	_	_
19-27	3450-3459	menstrual	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
19-28	3460-3465	cycle	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
19-29	3466-3472	phases	abstract[156]	giv[156]	_	_
19-30	3473-3474	,	_	_	_	_
19-31	3475-3479	etc.	_	_	_	_
19-32	3480-3481	)	_	_	_	_
19-33	3482-3484	or	_	_	_	_
19-34	3485-3494	variables	abstract[157]	new[157]	_	_
19-35	3495-3502	related	abstract[157]	new[157]	_	_
19-36	3503-3505	to	abstract[157]	new[157]	_	_
19-37	3506-3510	some	abstract[157]|abstract[158]	new[157]|new[158]	appos	19-44[162_158]
19-38	3511-3519	physical	abstract[157]|abstract[158]	new[157]|new[158]	_	_
19-39	3520-3535	characteristics	abstract[157]|abstract[158]	new[157]|new[158]	_	_
19-40	3536-3538	of	abstract[157]|abstract[158]	new[157]|new[158]	_	_
19-41	3539-3542	the	abstract[157]|abstract[158]|animal[159]	new[157]|new[158]|giv[159]	_	_
19-42	3543-3551	subjects	abstract[157]|abstract[158]|animal[159]	new[157]|new[158]|giv[159]	_	_
19-43	3552-3553	(	abstract[157]	new[157]	_	_
19-44	3554-3558	i.e.	abstract[157]|abstract[162]	new[157]|giv[162]	_	_
19-45	3559-3560	,	abstract[157]|abstract[162]	new[157]|giv[162]	_	_
19-46	3561-3564	the	abstract[157]|abstract[162]	new[157]|giv[162]	_	_
19-47	3565-3569	body	abstract[157]|object|abstract[162]	new[157]|new|giv[162]	_	_
19-48	3570-3574	mass	abstract[157]|abstract|abstract[162]	new[157]|new|giv[162]	_	_
19-49	3575-3580	index	abstract[157]|abstract[162]	new[157]|giv[162]	_	_
19-50	3581-3582	)	abstract[157]	new[157]	_	_
19-51	3583-3584	,	abstract[157]	new[157]	_	_
19-52	3585-3589	even	abstract[157]	new[157]	_	_
19-53	3590-3596	though	abstract[157]	new[157]	_	_
19-54	3597-3601	none	abstract[157]|event[163]	new[157]|new[163]	_	_
19-55	3602-3604	of	abstract[157]|event[163]	new[157]|new[163]	_	_
19-56	3605-3608	the	abstract[157]|event[163]|person[164]	new[157]|new[163]|giv[164]	coref	20-37[173_164]
19-57	3609-3619	volunteers	abstract[157]|event[163]|person[164]	new[157]|new[163]|giv[164]	_	_
19-58	3620-3623	was	abstract[157]	new[157]	_	_
19-59	3624-3634	apparently	abstract[157]	new[157]	_	_
19-60	3635-3641	under-	abstract[157]	new[157]	_	_
19-61	3642-3644	or	abstract[157]	new[157]	_	_
19-62	3645-3655	overweight	abstract[157]	new[157]	_	_
19-63	3656-3657	.	_	_	_	_

#Text=Second , due to the necessity of keeping the overall length of the protocol reasonably low , we did not consider long-term ANS measurements that could be more precise in characterizing the overall stress state of the volunteers .
20-1	3658-3664	Second	_	_	_	_
20-2	3665-3666	,	_	_	_	_
20-3	3667-3670	due	_	_	_	_
20-4	3671-3673	to	_	_	_	_
20-5	3674-3677	the	abstract[165]	new[165]	_	_
20-6	3678-3687	necessity	abstract[165]	new[165]	_	_
20-7	3688-3690	of	abstract[165]	new[165]	_	_
20-8	3691-3698	keeping	abstract[165]	new[165]	_	_
20-9	3699-3702	the	abstract[165]|abstract[166]	new[165]|new[166]	_	_
20-10	3703-3710	overall	abstract[165]|abstract[166]	new[165]|new[166]	_	_
20-11	3711-3717	length	abstract[165]|abstract[166]	new[165]|new[166]	_	_
20-12	3718-3720	of	abstract[165]|abstract[166]	new[165]|new[166]	_	_
20-13	3721-3724	the	abstract[165]|abstract[166]|abstract[167]	new[165]|new[166]|giv[167]	_	_
20-14	3725-3733	protocol	abstract[165]|abstract[166]|abstract[167]	new[165]|new[166]|giv[167]	_	_
20-15	3734-3744	reasonably	abstract[165]	new[165]	_	_
20-16	3745-3748	low	abstract[165]	new[165]	_	_
20-17	3749-3750	,	_	_	_	_
20-18	3751-3753	we	person	giv	ana	21-8
20-19	3754-3757	did	_	_	_	_
20-20	3758-3761	not	_	_	_	_
20-21	3762-3770	consider	_	_	_	_
20-22	3771-3780	long-term	abstract[170]	new[170]	_	_
20-23	3781-3784	ANS	abstract|abstract[170]	giv|new[170]	coref	22-25
20-24	3785-3797	measurements	abstract[170]	new[170]	_	_
20-25	3798-3802	that	abstract[170]	new[170]	_	_
20-26	3803-3808	could	abstract[170]	new[170]	_	_
20-27	3809-3811	be	abstract[170]	new[170]	_	_
20-28	3812-3816	more	abstract[170]	new[170]	_	_
20-29	3817-3824	precise	abstract[170]	new[170]	_	_
20-30	3825-3827	in	_	_	_	_
20-31	3828-3842	characterizing	_	_	_	_
20-32	3843-3846	the	abstract[172]	new[172]	coref	21-34[185_172]
20-33	3847-3854	overall	abstract[172]	new[172]	_	_
20-34	3855-3861	stress	abstract|abstract[172]	giv|new[172]	coref	22-15[191_0]
20-35	3862-3867	state	abstract[172]	new[172]	_	_
20-36	3868-3870	of	abstract[172]	new[172]	_	_
20-37	3871-3874	the	abstract[172]|person[173]	new[172]|giv[173]	_	_
20-38	3875-3885	volunteers	abstract[172]|person[173]	new[172]|giv[173]	_	_
20-39	3886-3887	.	_	_	_	_

#Text=Third , for the same reason , we decided not to administer stress-related questionnaires , such as Visual Analogue Scale ( VAS ) or State-Trait Anxiety Inventory ( STAI ) , to monitor both state and trait anxiety .
21-1	3888-3893	Third	_	_	_	_
21-2	3894-3895	,	_	_	_	_
21-3	3896-3899	for	_	_	_	_
21-4	3900-3903	the	abstract[174]	new[174]	coref	23-4[195_174]
21-5	3904-3908	same	abstract[174]	new[174]	_	_
21-6	3909-3915	reason	abstract[174]	new[174]	_	_
21-7	3916-3917	,	_	_	_	_
21-8	3918-3920	we	person	giv	ana	23-9
21-9	3921-3928	decided	_	_	_	_
21-10	3929-3932	not	_	_	_	_
21-11	3933-3935	to	_	_	_	_
21-12	3936-3946	administer	_	_	_	_
21-13	3947-3961	stress-related	abstract[176]	new[176]	_	_
21-14	3962-3976	questionnaires	abstract[176]	new[176]	_	_
21-15	3977-3978	,	abstract[176]	new[176]	_	_
21-16	3979-3983	such	abstract[176]	new[176]	_	_
21-17	3984-3986	as	abstract[176]	new[176]	_	_
21-18	3987-3993	Visual	abstract[176]|person|abstract[178]|abstract[179]	new[176]|new|new[178]|new[179]	appos	21-22[0_179]
21-19	3994-4002	Analogue	abstract[176]|abstract[178]|abstract[179]	new[176]|new[178]|new[179]	_	_
21-20	4003-4008	Scale	abstract[176]|abstract[179]	new[176]|new[179]	_	_
21-21	4009-4010	(	_	_	_	_
21-22	4011-4014	VAS	abstract	giv	_	_
21-23	4015-4016	)	_	_	_	_
21-24	4017-4019	or	_	_	_	_
21-25	4020-4031	State-Trait	abstract|abstract[182]|abstract[183]	new|new[182]|new[183]	appos|coref	21-29[0_183]|21-34[187_182]
21-26	4032-4039	Anxiety	abstract[182]|abstract[183]	new[182]|new[183]	_	_
21-27	4040-4049	Inventory	abstract[183]	new[183]	_	_
21-28	4050-4051	(	_	_	_	_
21-29	4052-4056	STAI	abstract	giv	ana	24-9
21-30	4057-4058	)	_	_	_	_
21-31	4059-4060	,	_	_	_	_
21-32	4061-4063	to	_	_	_	_
21-33	4064-4071	monitor	_	_	_	_
21-34	4072-4076	both	abstract[185]|abstract[187]	giv[185]|giv[187]	_	_
21-35	4077-4082	state	abstract[185]|abstract[187]	giv[185]|giv[187]	_	_
21-36	4083-4086	and	abstract[187]	giv[187]	_	_
21-37	4087-4092	trait	abstract|abstract[187]	new|giv[187]	_	_
21-38	4093-4100	anxiety	abstract[187]	giv[187]	_	_
21-39	4101-4102	.	_	_	_	_

#Text=Such protocols can be applied in future studies , allowing assessing possible correlations between the subjective , perceived stress and the variations of the ANS parameters .
22-1	4103-4107	Such	abstract[188]	giv[188]	coref	29-7[241_188]
22-2	4108-4117	protocols	abstract[188]	giv[188]	_	_
22-3	4118-4121	can	_	_	_	_
22-4	4122-4124	be	_	_	_	_
22-5	4125-4132	applied	_	_	_	_
22-6	4133-4135	in	_	_	_	_
22-7	4136-4142	future	abstract[189]	new[189]	coref	25-11[206_189]
22-8	4143-4150	studies	abstract[189]	new[189]	_	_
22-9	4151-4152	,	_	_	_	_
22-10	4153-4161	allowing	_	_	_	_
22-11	4162-4171	assessing	_	_	_	_
22-12	4172-4180	possible	abstract[190]	giv[190]	_	_
22-13	4181-4193	correlations	abstract[190]	giv[190]	_	_
22-14	4194-4201	between	abstract[190]	giv[190]	_	_
22-15	4202-4205	the	abstract[190]|abstract[191]	giv[190]|giv[191]	_	_
22-16	4206-4216	subjective	abstract[190]|abstract[191]	giv[190]|giv[191]	_	_
22-17	4217-4218	,	abstract[190]|abstract[191]	giv[190]|giv[191]	_	_
22-18	4219-4228	perceived	abstract[190]|abstract[191]	giv[190]|giv[191]	_	_
22-19	4229-4235	stress	abstract[190]|abstract[191]	giv[190]|giv[191]	_	_
22-20	4236-4239	and	abstract[190]	giv[190]	_	_
22-21	4240-4243	the	abstract[190]|abstract[192]	giv[190]|new[192]	coref	26-27[213_192]
22-22	4244-4254	variations	abstract[190]|abstract[192]	giv[190]|new[192]	_	_
22-23	4255-4257	of	abstract[190]|abstract[192]	giv[190]|new[192]	_	_
22-24	4258-4261	the	abstract[190]|abstract[192]|abstract[194]	giv[190]|new[192]|giv[194]	_	_
22-25	4262-4265	ANS	abstract[190]|abstract[192]|abstract|abstract[194]	giv[190]|new[192]|giv|giv[194]	coref	28-27
22-26	4266-4276	parameters	abstract[190]|abstract[192]|abstract[194]	giv[190]|new[192]|giv[194]	_	_
22-27	4277-4278	.	_	_	_	_

#Text=Fourth , for the reason mentioned above , we decided to keep the recovery phase reasonably short .
23-1	4279-4285	Fourth	_	_	_	_
23-2	4286-4287	,	_	_	_	_
23-3	4288-4291	for	_	_	_	_
23-4	4292-4295	the	abstract[195]	giv[195]	_	_
23-5	4296-4302	reason	abstract[195]	giv[195]	_	_
23-6	4303-4312	mentioned	abstract[195]	giv[195]	_	_
23-7	4313-4318	above	abstract[195]	giv[195]	_	_
23-8	4319-4320	,	_	_	_	_
23-9	4321-4323	we	person	giv	_	_
23-10	4324-4331	decided	_	_	_	_
23-11	4332-4334	to	_	_	_	_
23-12	4335-4339	keep	_	_	_	_
23-13	4340-4343	the	abstract[198]	giv[198]	coref	24-6[200_198]
23-14	4344-4352	recovery	event|abstract[198]	giv|giv[198]	_	_
23-15	4353-4358	phase	abstract[198]	giv[198]	_	_
23-16	4359-4369	reasonably	_	_	_	_
23-17	4370-4375	short	_	_	_	_
23-18	4376-4377	.	_	_	_	_

#Text=With a longer duration of this phase , one could have inferred the duration of the autonomic effects of both cognitive and sensory stimulation .
24-1	4378-4382	With	_	_	_	_
24-2	4383-4384	a	time[199]	new[199]	_	_
24-3	4385-4391	longer	time[199]	new[199]	_	_
24-4	4392-4400	duration	time[199]	new[199]	_	_
24-5	4401-4403	of	time[199]	new[199]	_	_
24-6	4404-4408	this	time[199]|abstract[200]	new[199]|giv[200]	_	_
24-7	4409-4414	phase	time[199]|abstract[200]	new[199]|giv[200]	_	_
24-8	4415-4416	,	_	_	_	_
24-9	4417-4420	one	abstract	giv	coref	28-30[237_0]
24-10	4421-4426	could	_	_	_	_
24-11	4427-4431	have	_	_	_	_
24-12	4432-4440	inferred	_	_	_	_
24-13	4441-4444	the	time[202]	new[202]	_	_
24-14	4445-4453	duration	time[202]	new[202]	_	_
24-15	4454-4456	of	time[202]	new[202]	_	_
24-16	4457-4460	the	time[202]|abstract[203]	new[202]|new[203]	_	_
24-17	4461-4470	autonomic	time[202]|abstract[203]	new[202]|new[203]	_	_
24-18	4471-4478	effects	time[202]|abstract[203]	new[202]|new[203]	_	_
24-19	4479-4481	of	time[202]|abstract[203]	new[202]|new[203]	_	_
24-20	4482-4486	both	time[202]|abstract[203]|event[204]	new[202]|new[203]|giv[204]	_	_
24-21	4487-4496	cognitive	time[202]|abstract[203]|event[204]	new[202]|new[203]|giv[204]	_	_
24-22	4497-4500	and	time[202]|abstract[203]|event[204]	new[202]|new[203]|giv[204]	_	_
24-23	4501-4508	sensory	time[202]|abstract[203]|event[204]	new[202]|new[203]|giv[204]	_	_
24-24	4509-4520	stimulation	time[202]|abstract[203]|event[204]	new[202]|new[203]|giv[204]	_	_
24-25	4521-4522	.	_	_	_	_

#Text=This limitation could be taken into account and solved in future studies .
25-1	4523-4527	This	abstract[205]	new[205]	_	_
25-2	4528-4538	limitation	abstract[205]	new[205]	_	_
25-3	4539-4544	could	_	_	_	_
25-4	4545-4547	be	_	_	_	_
25-5	4548-4553	taken	_	_	_	_
25-6	4554-4558	into	_	_	_	_
25-7	4559-4566	account	_	_	_	_
25-8	4567-4570	and	_	_	_	_
25-9	4571-4577	solved	_	_	_	_
25-10	4578-4580	in	_	_	_	_
25-11	4581-4587	future	abstract[206]	giv[206]	coref	27-1[219_206]
25-12	4588-4595	studies	abstract[206]	giv[206]	_	_
25-13	4596-4597	.	_	_	_	_

#Text=Fifth , the somewhat counterintuitive results retrieved in studying time- versus frequency-domain features were partially explained by the contrasting literature explanation regarding the physiological processes underlying frequency-domain variations , as explained in the signal analysis subsection of the Materials and Methods .
26-1	4598-4603	Fifth	_	_	_	_
26-2	4604-4605	,	_	_	_	_
26-3	4606-4609	the	abstract[207]	giv[207]	_	_
26-4	4610-4618	somewhat	abstract[207]	giv[207]	_	_
26-5	4619-4635	counterintuitive	abstract[207]	giv[207]	_	_
26-6	4636-4643	results	abstract[207]	giv[207]	_	_
26-7	4644-4653	retrieved	abstract[207]	giv[207]	_	_
26-8	4654-4656	in	_	_	_	_
26-9	4657-4665	studying	_	_	_	_
26-10	4666-4671	time-	abstract|abstract[209]	new|giv[209]	coref	27-13[223_209]
26-11	4672-4678	versus	abstract[209]	giv[209]	_	_
26-12	4679-4695	frequency-domain	abstract[209]	giv[209]	_	_
26-13	4696-4704	features	abstract[209]	giv[209]	_	_
26-14	4705-4709	were	_	_	_	_
26-15	4710-4719	partially	_	_	_	_
26-16	4720-4729	explained	_	_	_	_
26-17	4730-4732	by	_	_	_	_
26-18	4733-4736	the	abstract[211]	new[211]	_	_
26-19	4737-4748	contrasting	abstract[211]	new[211]	_	_
26-20	4749-4759	literature	abstract|abstract[211]	new|new[211]	_	_
26-21	4760-4771	explanation	abstract[211]	new[211]	_	_
26-22	4772-4781	regarding	abstract[211]	new[211]	_	_
26-23	4782-4785	the	abstract[211]|abstract[212]	new[211]|new[212]	_	_
26-24	4786-4799	physiological	abstract[211]|abstract[212]	new[211]|new[212]	_	_
26-25	4800-4809	processes	abstract[211]|abstract[212]	new[211]|new[212]	_	_
26-26	4810-4820	underlying	abstract[211]|abstract[212]	new[211]|new[212]	_	_
26-27	4821-4837	frequency-domain	abstract[211]|abstract[212]|abstract[213]	new[211]|new[212]|giv[213]	_	_
26-28	4838-4848	variations	abstract[211]|abstract[212]|abstract[213]	new[211]|new[212]|giv[213]	_	_
26-29	4849-4850	,	abstract[211]	new[211]	_	_
26-30	4851-4853	as	abstract[211]	new[211]	_	_
26-31	4854-4863	explained	abstract[211]	new[211]	_	_
26-32	4864-4866	in	abstract[211]	new[211]	_	_
26-33	4867-4870	the	abstract[211]|abstract[216]	new[211]|new[216]	_	_
26-34	4871-4877	signal	abstract[211]|abstract|abstract[215]|abstract[216]	new[211]|new|new[215]|new[216]	_	_
26-35	4878-4886	analysis	abstract[211]|abstract[215]|abstract[216]	new[211]|new[215]|new[216]	_	_
26-36	4887-4897	subsection	abstract[211]|abstract[216]	new[211]|new[216]	_	_
26-37	4898-4900	of	abstract[211]|abstract[216]	new[211]|new[216]	_	_
26-38	4901-4904	the	abstract[211]|abstract[216]|abstract[217]	new[211]|new[216]|new[217]	_	_
26-39	4905-4914	Materials	abstract[211]|abstract[216]|abstract[217]	new[211]|new[216]|new[217]	_	_
26-40	4915-4918	and	abstract[211]|abstract[216]	new[211]|new[216]	_	_
26-41	4919-4926	Methods	abstract[211]|abstract[216]|abstract	new[211]|new[216]|new	_	_
26-42	4927-4928	.	_	_	_	_

#Text=Further studies conducted on larger samples , and using other time-domains and more robust ECG features , including RMSSD and the Cardiac Vagal Index calculated from the Lorenz plot , could also help in clarifying this point .
27-1	4929-4936	Further	abstract[219]	giv[219]	coref	29-31[248_219]
27-2	4937-4944	studies	abstract[219]	giv[219]	_	_
27-3	4945-4954	conducted	abstract[219]	giv[219]	_	_
27-4	4955-4957	on	abstract[219]	giv[219]	_	_
27-5	4958-4964	larger	abstract[219]|object[220]	giv[219]|new[220]	_	_
27-6	4965-4972	samples	abstract[219]|object[220]	giv[219]|new[220]	_	_
27-7	4973-4974	,	abstract[219]	giv[219]	_	_
27-8	4975-4978	and	abstract[219]	giv[219]	_	_
27-9	4979-4984	using	abstract[219]	giv[219]	_	_
27-10	4985-4990	other	abstract[219]|place[221]	giv[219]|new[221]	_	_
27-11	4991-5003	time-domains	abstract[219]|place[221]	giv[219]|new[221]	_	_
27-12	5004-5007	and	abstract[219]	giv[219]	_	_
27-13	5008-5012	more	abstract[219]|abstract[223]	giv[219]|giv[223]	_	_
27-14	5013-5019	robust	abstract[219]|abstract[223]	giv[219]|giv[223]	_	_
27-15	5020-5023	ECG	abstract[219]|abstract|abstract[223]	giv[219]|new|giv[223]	_	_
27-16	5024-5032	features	abstract[219]|abstract[223]	giv[219]|giv[223]	_	_
27-17	5033-5034	,	abstract[219]|abstract[223]	giv[219]|giv[223]	_	_
27-18	5035-5044	including	abstract[219]|abstract[223]	giv[219]|giv[223]	_	_
27-19	5045-5050	RMSSD	abstract[219]|abstract[223]|abstract	giv[219]|giv[223]|new	_	_
27-20	5051-5054	and	abstract[219]|abstract[223]	giv[219]|giv[223]	_	_
27-21	5055-5058	the	abstract[219]|abstract[223]|abstract[226]	giv[219]|giv[223]|new[226]	_	_
27-22	5059-5066	Cardiac	abstract[219]|abstract[223]|abstract[226]	giv[219]|giv[223]|new[226]	_	_
27-23	5067-5072	Vagal	abstract[219]|abstract[223]|person|abstract[226]	giv[219]|giv[223]|new|new[226]	_	_
27-24	5073-5078	Index	abstract[219]|abstract[223]|abstract[226]	giv[219]|giv[223]|new[226]	_	_
27-25	5079-5089	calculated	abstract[219]|abstract[223]|abstract[226]	giv[219]|giv[223]|new[226]	_	_
27-26	5090-5094	from	abstract[219]|abstract[223]|abstract[226]	giv[219]|giv[223]|new[226]	_	_
27-27	5095-5098	the	abstract[219]|abstract[223]|abstract[226]|abstract[228]	giv[219]|giv[223]|new[226]|new[228]	_	_
27-28	5099-5105	Lorenz	abstract[219]|abstract[223]|abstract[226]|person|abstract[228]	giv[219]|giv[223]|new[226]|new|new[228]	_	_
27-29	5106-5110	plot	abstract[219]|abstract[223]|abstract[226]|abstract[228]	giv[219]|giv[223]|new[226]|new[228]	_	_
27-30	5111-5112	,	_	_	_	_
27-31	5113-5118	could	_	_	_	_
27-32	5119-5123	also	_	_	_	_
27-33	5124-5128	help	_	_	_	_
27-34	5129-5131	in	_	_	_	_
27-35	5132-5142	clarifying	_	_	_	_
27-36	5143-5147	this	abstract[229]	new[229]	_	_
27-37	5148-5153	point	abstract[229]	new[229]	_	_
27-38	5154-5155	.	_	_	_	_

#Text=Finally , the administration of both pleasant and unpleasant odors would have represented a possible confounding factor if one â€™s aim was to control the selective ANS response to one of the two categories .
28-1	5156-5163	Finally	_	_	_	_
28-2	5164-5165	,	_	_	_	_
28-3	5166-5169	the	event[230]	new[230]	_	_
28-4	5170-5184	administration	event[230]	new[230]	_	_
28-5	5185-5187	of	event[230]	new[230]	_	_
28-6	5188-5192	both	event[230]|abstract[231]	new[230]|new[231]	coref	29-17[0_231]
28-7	5193-5201	pleasant	event[230]|abstract[231]	new[230]|new[231]	_	_
28-8	5202-5205	and	event[230]|abstract[231]	new[230]|new[231]	_	_
28-9	5206-5216	unpleasant	event[230]|abstract[231]	new[230]|new[231]	_	_
28-10	5217-5222	odors	event[230]|abstract[231]	new[230]|new[231]	_	_
28-11	5223-5228	would	_	_	_	_
28-12	5229-5233	have	_	_	_	_
28-13	5234-5245	represented	_	_	_	_
28-14	5246-5247	a	abstract[232]	new[232]	_	_
28-15	5248-5256	possible	abstract[232]	new[232]	_	_
28-16	5257-5268	confounding	abstract[232]	new[232]	_	_
28-17	5269-5275	factor	abstract[232]	new[232]	_	_
28-18	5276-5278	if	_	_	_	_
28-19	5279-5282	one	person[233]|abstract[234]	giv[233]|new[234]	_	_
28-20	5283-5285	â€™s	person[233]|abstract[234]	giv[233]|new[234]	_	_
28-21	5286-5289	aim	abstract[234]	new[234]	_	_
28-22	5290-5293	was	_	_	_	_
28-23	5294-5296	to	_	_	_	_
28-24	5297-5304	control	_	_	_	_
28-25	5305-5308	the	abstract[236]	giv[236]	_	_
28-26	5309-5318	selective	abstract[236]	giv[236]	_	_
28-27	5319-5322	ANS	abstract|abstract[236]	giv|giv[236]	_	_
28-28	5323-5331	response	abstract[236]	giv[236]	_	_
28-29	5332-5334	to	abstract[236]	giv[236]	_	_
28-30	5335-5338	one	abstract[236]|abstract[237]	giv[236]|giv[237]	_	_
28-31	5339-5341	of	abstract[236]|abstract[237]	giv[236]|giv[237]	_	_
28-32	5342-5345	the	abstract[236]|abstract[237]|abstract[238]	giv[236]|giv[237]|new[238]	_	_
28-33	5346-5349	two	abstract[236]|abstract[237]|abstract[238]	giv[236]|giv[237]|new[238]	_	_
28-34	5350-5360	categories	abstract[236]|abstract[237]|abstract[238]	giv[236]|giv[237]|new[238]	_	_
28-35	5361-5362	.	_	_	_	_

#Text=In light of such considerations , future protocols could be structured starting from the selection of odors based on their hedonic tone , even referring to pleasantness data reported in previously published studies .
29-1	5363-5365	In	_	_	_	_
29-2	5366-5371	light	abstract[239]	new[239]	_	_
29-3	5372-5374	of	abstract[239]	new[239]	_	_
29-4	5375-5379	such	abstract[239]|abstract[240]	new[239]|giv[240]	_	_
29-5	5380-5394	considerations	abstract[239]|abstract[240]	new[239]|giv[240]	_	_
29-6	5395-5396	,	_	_	_	_
29-7	5397-5403	future	abstract[241]	giv[241]	_	_
29-8	5404-5413	protocols	abstract[241]	giv[241]	_	_
29-9	5414-5419	could	_	_	_	_
29-10	5420-5422	be	_	_	_	_
29-11	5423-5433	structured	_	_	_	_
29-12	5434-5442	starting	_	_	_	_
29-13	5443-5447	from	_	_	_	_
29-14	5448-5451	the	abstract[242]	new[242]	_	_
29-15	5452-5461	selection	abstract[242]	new[242]	_	_
29-16	5462-5464	of	abstract[242]	new[242]	_	_
29-17	5465-5470	odors	abstract[242]|abstract	new[242]|giv	ana	29-20
29-18	5471-5476	based	abstract[242]	new[242]	_	_
29-19	5477-5479	on	abstract[242]	new[242]	_	_
29-20	5480-5485	their	abstract[242]|abstract|abstract[245]	new[242]|giv|new[245]	_	_
29-21	5486-5493	hedonic	abstract[242]|abstract[245]	new[242]|new[245]	_	_
29-22	5494-5498	tone	abstract[242]|abstract[245]	new[242]|new[245]	_	_
29-23	5499-5500	,	_	_	_	_
29-24	5501-5505	even	_	_	_	_
29-25	5506-5515	referring	_	_	_	_
29-26	5516-5518	to	_	_	_	_
29-27	5519-5531	pleasantness	abstract|abstract[247]	new|new[247]	_	_
29-28	5532-5536	data	abstract[247]	new[247]	_	_
29-29	5537-5545	reported	abstract[247]	new[247]	_	_
29-30	5546-5548	in	abstract[247]	new[247]	_	_
29-31	5549-5559	previously	abstract[247]|abstract[248]	new[247]|giv[248]	_	_
29-32	5560-5569	published	abstract[247]|abstract[248]	new[247]|giv[248]	_	_
29-33	5570-5577	studies	abstract[247]|abstract[248]	new[247]|giv[248]	_	_
29-34	5578-5579	.	_	_	_	_
